Cargando…
Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
BACKGROUND: Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sang...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632486/ https://www.ncbi.nlm.nih.gov/pubmed/26530098 http://dx.doi.org/10.1186/s12885-015-1854-0 |
_version_ | 1782399041871544320 |
---|---|
author | Grotta, Simona D’Elia, Gemma Scavelli, Rossana Genovese, Silvia Surace, Cecilia Sirleto, Pietro Cozza, Raffaele Romanzo, Antonino De Ioris, Maria Antonietta Valente, Paola Tomaiuolo, Anna Cristina Lepri, Francesca Romana Franchin, Tiziana Ciocca, Laura Russo, Serena Locatelli, Franco Angioni, Adriano |
author_facet | Grotta, Simona D’Elia, Gemma Scavelli, Rossana Genovese, Silvia Surace, Cecilia Sirleto, Pietro Cozza, Raffaele Romanzo, Antonino De Ioris, Maria Antonietta Valente, Paola Tomaiuolo, Anna Cristina Lepri, Francesca Romana Franchin, Tiziana Ciocca, Laura Russo, Serena Locatelli, Franco Angioni, Adriano |
author_sort | Grotta, Simona |
collection | PubMed |
description | BACKGROUND: Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sanger sequencing. Nevertheless, these techniques show some limitations. We report our experience on a cohort of RB patients using a combined approach of Next-Generation Sequencing (NGS) and RB1 custom array-Comparative Genomic Hybridization (aCGH). METHODS: A total of 65 patients with retinoblastoma were studied: 29 cases of bilateral RB and 36 cases of unilateral RB. All patients were previously tested with conventional cytogenetics and MLPA techniques. Fifty-three samples were then analysed using NGS. Eleven cases were analysed by RB1 custom aCGH. One last case was studied only by classic cytogenetics. Finally, it has been tested, in a lab sensitivity assay, the capability of NGS to detect artificial mosaicism series in previously recognized samples prepared at 3 different mosaicism frequencies: 10, 5, 1 %. RESULTS: Of the 29 cases of bilateral RB, 28 resulted positive (96.5 %) to the genetic investigation: 22 point mutations and 6 genomic rearrangements (four intragenic and two macrodeletion). A novel germline intragenic duplication, from exon18 to exon 23, was identified in a proband with bilateral RB. Of the 36 available cases of unilateral RB, 8 patients resulted positive (22 %) to the genetic investigation: 3 patients showed point mutations while 5 carried large deletion. Finally, we successfully validated, in a lab sensitivity assay, the capability of NGS to accurately measure level of artificial mosaicism down to 1 %. CONCLUSIONS: NGS and RB1-custom aCGH have demonstrated to be an effective combined approach in order to optimize the overall diagnostic procedures of RB. Custom aCGH is able to accurately detect genomic rearrangements allowing the characterization of their extension. NGS is extremely accurate in detecting single nucleotide variants, relatively simple to perform, cost savings and efficient and has confirmed a high sensitivity and accuracy in identifying low levels of artificial mosaicisms. |
format | Online Article Text |
id | pubmed-4632486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46324862015-11-05 Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma Grotta, Simona D’Elia, Gemma Scavelli, Rossana Genovese, Silvia Surace, Cecilia Sirleto, Pietro Cozza, Raffaele Romanzo, Antonino De Ioris, Maria Antonietta Valente, Paola Tomaiuolo, Anna Cristina Lepri, Francesca Romana Franchin, Tiziana Ciocca, Laura Russo, Serena Locatelli, Franco Angioni, Adriano BMC Cancer Research Article BACKGROUND: Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sanger sequencing. Nevertheless, these techniques show some limitations. We report our experience on a cohort of RB patients using a combined approach of Next-Generation Sequencing (NGS) and RB1 custom array-Comparative Genomic Hybridization (aCGH). METHODS: A total of 65 patients with retinoblastoma were studied: 29 cases of bilateral RB and 36 cases of unilateral RB. All patients were previously tested with conventional cytogenetics and MLPA techniques. Fifty-three samples were then analysed using NGS. Eleven cases were analysed by RB1 custom aCGH. One last case was studied only by classic cytogenetics. Finally, it has been tested, in a lab sensitivity assay, the capability of NGS to detect artificial mosaicism series in previously recognized samples prepared at 3 different mosaicism frequencies: 10, 5, 1 %. RESULTS: Of the 29 cases of bilateral RB, 28 resulted positive (96.5 %) to the genetic investigation: 22 point mutations and 6 genomic rearrangements (four intragenic and two macrodeletion). A novel germline intragenic duplication, from exon18 to exon 23, was identified in a proband with bilateral RB. Of the 36 available cases of unilateral RB, 8 patients resulted positive (22 %) to the genetic investigation: 3 patients showed point mutations while 5 carried large deletion. Finally, we successfully validated, in a lab sensitivity assay, the capability of NGS to accurately measure level of artificial mosaicism down to 1 %. CONCLUSIONS: NGS and RB1-custom aCGH have demonstrated to be an effective combined approach in order to optimize the overall diagnostic procedures of RB. Custom aCGH is able to accurately detect genomic rearrangements allowing the characterization of their extension. NGS is extremely accurate in detecting single nucleotide variants, relatively simple to perform, cost savings and efficient and has confirmed a high sensitivity and accuracy in identifying low levels of artificial mosaicisms. BioMed Central 2015-11-04 /pmc/articles/PMC4632486/ /pubmed/26530098 http://dx.doi.org/10.1186/s12885-015-1854-0 Text en © Grotta et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Grotta, Simona D’Elia, Gemma Scavelli, Rossana Genovese, Silvia Surace, Cecilia Sirleto, Pietro Cozza, Raffaele Romanzo, Antonino De Ioris, Maria Antonietta Valente, Paola Tomaiuolo, Anna Cristina Lepri, Francesca Romana Franchin, Tiziana Ciocca, Laura Russo, Serena Locatelli, Franco Angioni, Adriano Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma |
title | Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma |
title_full | Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma |
title_fullStr | Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma |
title_full_unstemmed | Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma |
title_short | Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma |
title_sort | advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632486/ https://www.ncbi.nlm.nih.gov/pubmed/26530098 http://dx.doi.org/10.1186/s12885-015-1854-0 |
work_keys_str_mv | AT grottasimona advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT deliagemma advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT scavellirossana advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT genovesesilvia advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT suracececilia advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT sirletopietro advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT cozzaraffaele advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT romanzoantonino advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT deiorismariaantonietta advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT valentepaola advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT tomaiuoloannacristina advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT leprifrancescaromana advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT franchintiziana advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT cioccalaura advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT russoserena advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT locatellifranco advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma AT angioniadriano advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma |